临床病理特征 | SNAT3蛋白 | χ2值 | P值 | |
高表达(n = 54) | 低表达(n = 42) | |||
年龄 <60岁(n = 49) ≥60岁(n = 47) |
26 (48.1%) 28 (51.9%) |
23 (54.8%) 19 (45.2%) | 0.414 | 0.520 |
性别 男(n = 57) 女(n = 39) |
33 (61.1%) 21 (38.9%) |
24 (57.1%) 18 (42.9%) | 0.384 | 0.533 |
肿瘤大小 ≤5 cm (n = 51) >5 cm (n = 45) |
23 (42.6%) 31 (57.4%) |
28 (66.7%) 14 (33.3%) | 5.498 | 0.019 |
癌浸润深度 T1 + T2 (n = 39) T3 + T4 (n = 57) |
14 (25.9%) 40 (74.1%) |
25 (59.5%) 17 (40.5%) | 11.056 | 0.001 |
癌细胞分化程度 分化型(n = 78) 未分化型(n = 18) |
38 (48.7%) 16 (88.9%) |
40 (51.3%) 2 (11.1%) | 9.590 | 0.002 |
淋巴结转移 阴性(n = 48) 阳性(n = 48) |
19 (35.2%) 35 (64.8%) |
29 (69.0%) 13 (31.0%) | 10.836 | 0.001 |
临床分期 I + II (n = 38) III + IV (n = 58) |
13 (24.1%) 41 (75.9%) |
25 (59.5%) 17 (40.5%) | 12.414 | 0.001 |
复发转移 无(n = 74) 有(n = 22) |
36 (48.6%) 18 (81.8%) |
38 (51.4%) 4 (18.2%) | 7.582 | 0.006 |